Saniona AB (STU:30S) Short Interest


STU:30S Saniona AB STU:30S
61 GF Score
Price €1.14
GF Value €2.44
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Saniona AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:30S vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Saniona AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Saniona AB Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Saniona AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Saniona AB's Short Interest falls into.


STU:30S
61GF Score
Saniona AB STU:30S
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Saniona AB (STU:30S) Overvalued in 2026?

Based on GuruFocus' analysis, Saniona AB stock appears to be undervalued. The current stock price of €1.14 is trading 53.2% below its estimated GF Value™ of €2.44. GuruFocus considers Saniona AB to be Significantly Undervalued.

Key valuation signals for STU:30S:

  • Short Interest:
  • GF Value™: €2.44 vs. price of €1.14 (53.2% below fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the STU:30S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Saniona AB Business Description

Address Murervangen 42, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
61GF Score

Get the complete analysis for STU:30S

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.14
Price
€2.44
GF Value